BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

428 related articles for article (PubMed ID: 28914501)

  • 21. Clinical practice. Care of transsexual persons.
    Gooren LJ
    N Engl J Med; 2011 Mar; 364(13):1251-7. PubMed ID: 21449788
    [No Abstract]   [Full Text] [Related]  

  • 22. Effect of 2,3,7,8-tetrachlorodibenzo-p-dioxin on testicular spermatogenesis-related panels and serum sex hormone levels in rats.
    Choi JS; Kim IW; Hwang SY; Shin BJ; Kim SK
    BJU Int; 2008 Jan; 101(2):250-5. PubMed ID: 17868417
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gender affirming hormone therapy and transgender women fertility: Histologic predictors of germ cell presence.
    Marins LR; Rosito TE; Kliemann LM; Capp E; Corleta HVE
    Rev Bras Ginecol Obstet; 2024; 46():. PubMed ID: 38765523
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Levonorgestrel implants (Norplant II) for male contraception clinical trials: combination with transdermal and injectable testosterone.
    Gonzalo IT; Swerdloff RS; Nelson AL; Clevenger B; Garcia R; Berman N; Wang C
    J Clin Endocrinol Metab; 2002 Aug; 87(8):3562-72. PubMed ID: 12161475
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cross-sex hormone administration changes pain in transsexual women and men.
    Aloisi AM; Bachiocco V; Costantino A; Stefani R; Ceccarelli I; Bertaccini A; Meriggiola MC
    Pain; 2007 Nov; 132 Suppl 1():S60-S67. PubMed ID: 17379410
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MANAGEMENT OF ENDOCRINE DISEASE: Optimal feminizing hormone treatment in transgender people.
    Glintborg D; T'Sjoen G; Ravn P; Andersen MS
    Eur J Endocrinol; 2021 Jun; 185(2):R49-R63. PubMed ID: 34081614
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mortality and morbidity in transsexual subjects treated with cross-sex hormones.
    van Kesteren PJ; Asscheman H; Megens JA; Gooren LJ
    Clin Endocrinol (Oxf); 1997 Sep; 47(3):337-42. PubMed ID: 9373456
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fertility Preservation in Male to Female Transgender Patients.
    Liu W; Schulster ML; Alukal JP; Najari BB
    Urol Clin North Am; 2019 Nov; 46(4):487-493. PubMed ID: 31582023
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Psychological Outcomes and Reproductive Issues Among Gender Dysphoric Individuals.
    Schmidt L; Levine R
    Endocrinol Metab Clin North Am; 2015 Dec; 44(4):773-85. PubMed ID: 26568492
    [TBL] [Abstract][Full Text] [Related]  

  • 30. How young is too young: ethical concerns in genital surgery of the transgender MTF adolescent.
    Milrod C
    J Sex Med; 2014 Feb; 11(2):338-46. PubMed ID: 24238576
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Morbidity in transsexual patients with cross-gender hormone self-treatment].
    Becerra Fernández A; de Luis Román DA; Piédrola Maroto G
    Med Clin (Barc); 1999 Oct; 113(13):484-7. PubMed ID: 10604171
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Deoxyribonucleic acid histogram of testes in primary transsexualism.
    Chiu AW; Chen MT; Chiang H; Wu LH; Fang RH; Chang LS
    Br J Urol; 1993 Oct; 72(4):495-7. PubMed ID: 8261307
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The sex difference of plasma homovanillic acid is unaffected by cross-sex hormone administration in transsexual subjects.
    Giltay EJ; Kho KH; Blansjaar BA; Verbeek MM; Geurtz PB; Geleijnse JM; Gooren LJ
    J Endocrinol; 2005 Oct; 187(1):109-16. PubMed ID: 16214946
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation and Treatment of Gender Dysphoria to Prepare for Gender Confirmation Surgery.
    Hadj-Moussa M; Ohl DA; Kuzon WM
    Sex Med Rev; 2018 Oct; 6(4):607-617. PubMed ID: 29891226
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sexual functioning in transsexuals following hormone therapy and genital surgery: a review.
    Klein C; Gorzalka BB
    J Sex Med; 2009 Nov; 6(11):2922-39; quiz 2940-1. PubMed ID: 20092545
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Activating effects of cross-sex hormones on cognitive functioning: a study of short-term and long-term hormone effects in transsexuals.
    Slabbekoorn D; van Goozen SH; Megens J; Gooren LJ; Cohen-Kettenis PT
    Psychoneuroendocrinology; 1999 May; 24(4):423-47. PubMed ID: 10341369
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genetic Link Between Gender Dysphoria and Sex Hormone Signaling.
    Foreman M; Hare L; York K; Balakrishnan K; Sánchez FJ; Harte F; Erasmus J; Vilain E; Harley VR
    J Clin Endocrinol Metab; 2019 Feb; 104(2):390-396. PubMed ID: 30247609
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reversal of the sex difference in serum leptin levels upon cross-sex hormone administration in transsexuals.
    Elbers JM; Asscheman H; Seidell JC; Frölich M; Meinders AE; Gooren LJ
    J Clin Endocrinol Metab; 1997 Oct; 82(10):3267-70. PubMed ID: 9329351
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Transsexualism: a Brain Disorder that Begins to Known].
    López Moratalla N; Calleja Canela A
    Cuad Bioet; 2016; 27(89):81-92. PubMed ID: 27124478
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Management of juvenile gender dysphoria.
    Hembree WC
    Curr Opin Endocrinol Diabetes Obes; 2013 Dec; 20(6):559-64. PubMed ID: 24468758
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.